RxDoctor Payments Data

David Barron

Radiation Oncology · Elyria, OHNPI 1235491440

Payments from drug & device makers

What this record shows

This record is dominated by consulting fees: $6,600 of the $9,872 with a category attached, or 66.9%. Boston Scientific accounts for 87.3% of it on its own, with 10 other manufacturers making up the rest. Reporting peaked in 2024 at $8,622 and has fallen 92.6% since, to $635 in 2025. Among radiation oncology clinicians in OH with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$9,872in general payments, 2019–2025

Across 30 payments — averaging $329.08 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Boston Scientific$9K
  • Sirtex Medical Inc$261
  • Stryker$252
  • Medtronic$151
  • Elekta, Inc.$151
  • Histosonics, Inc.$150
  • plus $293 from 5 others
$30,792in ownership & investment interests, 2019–2025

Across 1 payment — averaging $30,792 each. An ownership or investment interest held by the physician or an immediate family member.

  • Overture Orthopaedics$31K

What the payments were for

  • Consulting fees$6,60067%
  • Travel & lodging$1,35314%
  • Food & beverage$1,92019%

General payments by program year

19
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$9,872 in reported general payments places this provider in the 90th percentile of 255 radiation oncology providers in Ohio.

See all radiation oncology providers in Ohio

Medicare billing

Part B allowed, 2024
$173,851
Medicare patients
171
Services billed
2,053

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
MyrbetriqMirabegron12$5,545
Memantine Hcl12$842
Oxybutynin Chloride ErOxybutynin Chloride33$720
Mometasone Furoate34$678
Tamsulosin Hcl45$356
Ondansetron OdtOndansetron25$293
Silver Sulfadiazine29$171
Bicalutamide11$133
Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen38$116
Prednisone11$71
Levofloxacin31$45
Sulfamethoxazole-TrimethoprimSulfamethoxazole/Trimethoprim14$32
Lorazepam31$24

Paid to pharmacies, not to this prescriber.

Other radiation oncology in Elyria

See the full list for Ohio

Where these figures come from

Is this you, or does something look wrong? →